US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

317.20

+12.294.03%

Post-market: 317.870.6700+0.21%19:58 EDT

Volume:468.50K

Turnover:149.84M

Market Cap:689.75M

PE:- -

High:329.20

Open:311.70

Low:306.27

Close:304.91

52wk High:341.93

52wk Low:66.60

Shares:2.17M

Float Shares:2.17M

Volume Ratio:0.98

T/O Rate:21.55%

Dividend:1.02

Dividend Rate:0.32%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Exchange-Traded Funds Fall, US Equities Mixed After Midday

MT Newswires Live

Max Healthcare Shares Investor Presentation Ahead of Global Conference

Health Care Roundup: Market Talk

Analysts Conflicted on These Healthcare Names: Alpha Cognition Inc (ACOG) and TScan Therapeutics (TCRX)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)

Analysts’ Opinions Are Mixed on These Real Estate Stocks: Sabra Healthcare REIT (SBRA) and AvalonBay (AVB)

Sector Update: Healthcare

MT Newswires Live

Wall Street Analysts Are Neutral on Top Real Estate Picks

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

American Healthcare REIT, Inc. (AHR) Receives a Buy from Bank of America Securities

Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Cardinal Health (CAH) and Allogene Therapeutics (ALLO)

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

HAIXI PHARMA Gains US FDA Fast Track Status for Lead Candidate Targeting Wet AMD

Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101

Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) and Demant (OtherWILLF)

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases

Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)

Trian takes boosts stakes in GE Healthcare, Wendy’s

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LABU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":317.2,"timestamp":1787342400000,"preClose":304.91,"halted":0,"volume":468504,"hourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"delay":0,"changeRate":0.04030697582893301,"floatShares":2174486,"shares":2174486,"eps":0,"marketStatus":"Market Closed","change":12.29,"latestTime":"08-21 16:00:00 EDT","open":311.7,"high":329.2026,"low":306.27,"amount":149839169.98896,"amplitude":0.075211,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":304.91,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.00323,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":313.6,"preClose":304.91,"latestTime":"09:27 EDT","volume":3793,"amount":1185778.2804,"timestamp":1787318868980,"change":8.69,"changeRate":0.0285,"amplitude":0.022236},"postHourTrading":{"tag":"盘后","latestPrice":317.87,"preClose":317.2,"latestTime":"19:58 EDT","volume":6645,"amount":2111082.7734,"timestamp":1787356729854,"change":0.67,"changeRate":0.002112,"amplitude":0.006526},"volumeRatio":0.9815516107169615,"impliedVol":0.9442,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2174486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9815516107169615,"shares":2174486,"dividePrice":1.0247,"high":329.2026,"amplitude":0.075211,"preClose":304.91,"low":306.27,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":317.2,"eps":0,"divideRate":0.00323,"volume":468504,"delay":0,"ttmEps":0,"open":311.7,"prevYearClose":159.39,"prevWeekClose":276.54,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":276.54,"twentyDayClose":245.6,"sixtyDayClose":186},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660759439","title":"Exchange-Traded Funds Fall, US Equities Mixed After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2660759439","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660759439?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:12","pubTimestamp":1786986748,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV edged lower. Actively traded Invesco QQQ Trust (QQQ) added 0.1%.US equity indexes traded mixed, as speculation about Anthropic's Q","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLY","QQQ","RTH","RTH.AU","XLF","BITO","IYE","STT","SLV","USO",".DJI","VIS","XLG","XLV","QYLG","VHT.AU","GLD","ARKY","UNG","BETH","VDC",".IXIC","BETE","XLE","IYJ","LABU","XRT","XSD","XLI","VHT","FAS","BTF","IYK","STCE","DIA","IBB","IGM","IYH","XLK","IVW","EETH",".SPX","IYW","ETH","FAZ","SOXX","MNQmain","XLP","GRNY","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660643921","title":"Max Healthcare Shares Investor Presentation Ahead of Global Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660643921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660643921?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:03","pubTimestamp":1786986192,"startTime":"0","endTime":"0","summary":"Max Healthcare Institute Ltd ( ($IN:MAXHEALTH) ) just unveiled an announcement. Max Healthcare Institute Ltd, a major Indian hospital and healthcar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/max-healthcare-shares-investor-presentation-ahead-of-global-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/max-healthcare-shares-investor-presentation-ahead-of-global-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","BK4588","BK4137","BK4585","XLV","LABU","HCSG","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660643995","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660643995","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660643995?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:20","pubTimestamp":1786983600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0654 ET - Sandoz's tie-up with China's Henlius looks like a posi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4581","XLV","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660643642","title":"Analysts Conflicted on These Healthcare Names: Alpha Cognition Inc (ACOG) and TScan Therapeutics (TCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660643642","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660643642?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:40","pubTimestamp":1786981208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alpha Cognition Inc (ACOG) and TScan Therapeutics ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alpha-cognition-inc-acog-and-tscan-therapeutics-tcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-alpha-cognition-inc-acog-and-tscan-therapeutics-tcrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4139","BK4585","ACOG","LU0128526141.USD","BK4588","BK4581","TCRX","BK4539","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436400","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436400","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436400?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:30","pubTimestamp":1786980619,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmac...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-omniab-oabi-bicycle-therapeutics-bcyc-and-60-degrees-pharmaceuticals-inc-sxtp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-omniab-oabi-bicycle-therapeutics-bcyc-and-60-degrees-pharmaceuticals-inc-sxtp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","PRTO","HCSG","LU0128526141.USD","BK4139","BK4581","BK4121","BK4585","BK4137","BCYC","SXTP","XBI","OABI","BK4588","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436627","title":"Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436627?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:20","pubTimestamp":1786980007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Adagene (ADAG) and Natera (NTRA). Adagene (ADAG) M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2065170008.USD","LU2065171402.SGD","BK4137","BK4581","GNOM","LU0053671581.USD","LU0345770308.USD","LU0963586101.USD","LU2065169927.USD","LU2264538146.SGD","LABU","LU2065171311.SGD","LU0029874061.USD","LU0345770993.USD","LU0012050646.USD","BK4588","LU0128526141.USD","HCSG","NTRA","XBI","ADAG","XLV","HELX","LU2065731478.USD","LU2324357040.USD","LU1988902786.USD","LU1064131342.USD","BK4139","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243511","title":"Analysts’ Opinions Are Mixed on These Real Estate Stocks: Sabra Healthcare REIT (SBRA) and AvalonBay (AVB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243511?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:40","pubTimestamp":1786977632,"startTime":"0","endTime":"0","summary":"Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Sabra Healthcare REIT (SBRA) and AvalonBay (AVB)....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-real-estate-stocks-sabra-healthcare-reit-sbra-and-avalonbay-avb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-real-estate-stocks-sabra-healthcare-reit-sbra-and-avalonbay-avb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","DFRA","REIT","REIX","MDIV","PSCF","RITA","XLV","RJMG","PPTY","SBRA","YLDW","LU0029874061.USD","BK4203","IVRA","BPRE","BK4215","RNTY","LU0128526141.USD","NURE","XBI","HCSG","BK4225","LABU","IQRA","AVB","BK4581","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480066","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480066?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:04","pubTimestamp":1786971840,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Monday, with the State Street Health Care Select Sector SPDR ETF  0.5% lower and the iShares Biotechnology ETF  up 0.2%.Argenx  shares were nearly 12% higher after the company said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met its main goal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","LU0128526141.USD","LU1983260115.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","IE0034235188.USD","LU0320765992.SGD","LU0109394709.USD","BK4581","IBB","ARGX","BK4585","TBXU","LU0823416689.USD","IE00BJJMRZ35.SGD","BK4139","FDN","LU1883839398.USD","LU1894683264.USD","LU2324357040.USD","BK4588","BK4505","IE00B64PRP62.GBP","IE0002141913.USD","BK4550","LU0061475181.USD","LU0029874061.USD","BK4135","IE00B3QW5Z07.USD","IE00BFTCPJ56.SGD","XBI","FMED","LU0889565916.HKD","STT","IE00B4R5TH58.HKD","IE00BGHQF748.EUR","LABU","BK4137","HCSG","XLV","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480031","title":"Wall Street Analysts Are Neutral on Top Real Estate Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480031?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971672,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Healthcare Realty Trust (HR) and Kite Realty Group (KRG) with neutral ratings, indicating that the ex...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-neutral-on-top-real-estate-picks-blurbs-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-neutral-on-top-real-estate-picks-blurbs-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","KRG","BK4225","LABU","XBI","BK4080","SRET","HR","BK4203","BK4581","XLV","BK4231","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480044","title":"Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480044?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:01","pubTimestamp":1786971667,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-agomab-therapeutics-nv-adr-agmb-and-sana-biotechnology-sana-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-fortrea-holdings-inc-ftre-agomab-therapeutics-nv-adr-agmb-and-sana-biotechnology-sana-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","DIVL","BK4581","BK4137","LU0128526141.USD","FTRE","XBI","BK4007","XLV","SANA","BK4588","LABU","CVY","LU0029874061.USD","AADR","BK4139","SAPH","BK4121","DINT","ARMH","AGMB","APIE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660800764","title":"American Healthcare REIT, Inc. (AHR) Receives a Buy from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2660800764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660800764?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:57","pubTimestamp":1786971459,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Farrell Granath reiterated a Buy rating on American Healthcare REIT, Inc. today and set a price target of $71.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/american-healthcare-reit-inc-ahr-receives-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/american-healthcare-reit-inc-ahr-receives-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDIV","BK4207","UYG","IYF","LU0256863811.USD","REIX","IE00B19Z3581.USD","YLDW","BAC","BPRE","LU0106831901.USD","LU1894683264.USD","KBWB","LU1496350171.SGD","IVRA","LU0208291251.USD","RNTY","BK4582","IYG","XLV","LU0211331839.USD","IQRA","LU1201861249.SGD","LU1880398471.USD","XBI","LU1894683348.USD","BK4504","LU0130518102.USD","LU0683600562.USD","LU1989771016.USD","BK4553","VFH","LU0256863902.USD","TFNS","LU0070302665.USD","REIT","XLF","FTXO","LU2133065610.SGD","PGF","FNCL","DFRA","LU1201861165.SGD","BK4559","AHR","LU0234570918.USD","LABU","LU0234572021.USD","RJMG","PSCF","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660510480","title":"Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Cardinal Health (CAH) and Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660510480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660510480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:40","pubTimestamp":1786970438,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Silence Therapeutics (SLN), Cardinal Health (CAH) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-silence-therapeutics-sln-cardinal-health-cah-and-allogene-therapeutics-allo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-silence-therapeutics-sln-cardinal-health-cah-and-allogene-therapeutics-allo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0211328371.USD","LU0052756011.USD","CAH","LU1571399168.USD","LU0310800965.SGD","XBI","LU0006061336.USD","BK4588","BK4137","LU1880398554.USD","ALLO","SLN","LU0162691827.USD","LU0154236417.USD","LU0310799852.SGD","LU0889566641.SGD","BK4175","LU1880398471.USD","LU1983299246.USD","LABU","LU0029874061.USD","LU0072461881.USD","LU1267930490.SGD","BK4139","BK4505","LU0792757196.USD","LU0211327993.USD","LU1267930813.SGD","LU0128526141.USD","HCSG","XLV","LU1267930227.SGD","BK4581","LU0128525689.USD","SG9999001440.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487002","title":"Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487002","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487002?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:30","pubTimestamp":1786969800,"startTime":"0","endTime":"0","summary":"Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearanceNEW YORK, Aug.  17, 2026 (GLOBE NEWSW","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3346081/0/en/intelligent-bio-solutions-strengthens-quality-management-credentials-with-iso-recertification.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144208033","title":"HAIXI PHARMA Gains US FDA Fast Track Status for Lead Candidate Targeting Wet AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=1144208033","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144208033?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:54","pubTimestamp":1786967655,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) has announced that its independently developed innovative drug candidate, HX9428, from the HXP056 project, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK1191","BK4588","02637","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482660","title":"Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482660","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482660?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:40","pubTimestamp":1786966835,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) announced that it has scheduled an End-of-Phase 2 meeting with the FDA for October 1, to align on the design of a pivotal Phase 3...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-schedules-end-of-phase-2-meeting-with-fda-for-rad101-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-schedules-end-of-phase-2-meeting-with-fda-for-rad101-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","LABU","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660826694","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) and Demant (OtherWILLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660826694","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660826694?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:40","pubTimestamp":1786966813,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Achieve Life Sciences (ACHV), Mereo Biopharma Group Plc (MREO) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-achieve-life-sciences-achv-mereo-biopharma-group-plc-mreo-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-achieve-life-sciences-achv-mereo-biopharma-group-plc-mreo-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MREO","BK4505","BK4581","HCSG","XLV","ACHV","BK4139","XBI","LU0029874061.USD","LABU","BK4588","BK4585","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487966","title":"Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487966","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487966?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:30","pubTimestamp":1786966200,"startTime":"0","endTime":"0","summary":"RAD 101 Phase 2b trial demonstrated 93% concordance with MRI across all evaluable lesions, meeting the Phase 2 trial's primary endpoint End-of-Phase 2 meeting with the U.S. FDA scheduled for October 1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/17/3345992/0/en/radiopharm-theranostics-to-meet-with-u-s-fda-to-align-on-pivotal-phase-3-trial-design-for-rad-101-in-diagnosis-of-brain-metastases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","RADX","LABU","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484873","title":"Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484873","media":"Dow Jones","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484873?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:00","pubTimestamp":1786964400,"startTime":"0","endTime":"0","summary":"Key recent and second quarter highlights include:-- Completed first-cycle FDA review of the Company's ANDA for. preservative-free ketamine with no drug-related major deficiencies. The. sole remaining item, a manufacturer's attestation on the vial, has been. -- Initiation of commercial scale manufacturing of preservative-free. ketamine building to launch stock of 5 million doses to be ready for. -- Selected by the Defense Advanced Research Projects Agency  as. prime contractor for SPARC-TMS, an FDA-approved Phase 2/3 trial of. NRX-101 with robotic TMS. Anticipated non-dilutive funding exceeds $11.5. -- The Company is advancing its NRX-100 NDA on Real World Evidence from more. than 65,000 patients, leveraging a Presidential Executive Order and. Congressional budget language that encourage FDA use of such evidence in. -- Closed an institutionally-supported, underwritten public offering of. common stock for gross proceeds of $22.3 million, including full exercise. of the underwriters' opti","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMZA","LABU","TNGY","EIPI","MLPA","UMI","R","AMLP","BK4144","BK4588","ET","NQmain","BK4007","BK4232","NRXP","EMLP","USAI","BK4590","LCLG","ENFR","BK4581","BK4585","BK4561","PSIL","MDST","EIPX","TPZ","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048525","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048525?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:01","pubTimestamp":1786957287,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Phathom Pharmaceuticals (PHAT) and BioMarin Pharmace...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4007","LU0128526141.USD","XBI","BK4137","BK4566","XLV","BMRN","LABU","BK4139","IE0002270589.USD","BK4581","IE00B19Z3B42.SGD","BK4585","PHAT","BK4588","IE00B7SZLL34.SGD","IE00B19Z3581.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660485889","title":"Trian takes boosts stakes in GE Healthcare, Wendy’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2660485889","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660485889?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:42","pubTimestamp":1786956142,"startTime":"0","endTime":"0","summary":"Nelson Peltz’s Trian Fund Management disclosed in an SEC filing its holdings as of June 30, 2026. Trian increased its stake in two holdings, includ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trian-takes-boosts-stakes-in-ge-healthcare-wendys-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trian-takes-boosts-stakes-in-ge-healthcare-wendys-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","XLV","LU2543165471.USD","LU1551013425.SGD","LU0077335932.USD","LU2087625088.SGD","EXI","LU0029874061.USD","PPA","LU0353189763.USD","LU1261432733.SGD","LU2168563687.JPY","LU0640476718.USD","UXI","LABU","LU1084165304.USD","BK4501","BK4581","LU0943347566.SGD","DFEN","LU1119994496.HKD","XBI","LU0689472784.USD","LU1280957306.USD","LU2264538146.SGD","XAR","BK4543","LU0149725797.USD","LU2168564065.EUR","MISL","LU0820561909.HKD","BK4206","GE","LU2756315664.SGD","NATO","LU2168564149.EUR","LU0354030438.USD","TRUI","LU1064131342.USD","LU1093756168.USD","LU1366192091.USD","LU0354030511.USD","LU0820562030.AUD","LU0868494617.USD","LU0820561818.USD","BK4137","LU0267386448.USD","BK4187","ITA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":9,"totalSize":391,"code":"91000000","status":"200"}]}}